Self-inactivating Retroviral Vector-mediated Gene Transfer Induces Oncogene Activation and Immortalization of Primary Murine Bone Marrow Cells

被引:27
作者
Bosticardo, Marita
Ghosh, Amrita
Du, Yang [2 ,3 ]
Jenkins, Nancy A. [2 ]
Copeland, Neal G. [2 ]
Candotti, Fabio [1 ]
机构
[1] NHGRI, Disorders Immun Sect, GMBB, Bethesda, MD 20892 USA
[2] NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21701 USA
[3] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA
关键词
BIDIRECTIONAL TRANSCRIPTIONAL ACTIVITY; SEVERE COMBINED IMMUNODEFICIENCY; INSERTIONAL MUTAGENESIS; MOUSE MODEL; THERAPY; INTEGRATION; SCID-X1; MARKING; GENOTOXICITY; PROMOTER;
D O I
10.1038/mt.2009.172
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Insertional mutagenesis leading to insurgence of leukemia has been shown as a consequence of retroviral (RV)-mediated gene transfer in animal models and in clinical trials of gene therapy for X-linked severe combined immunodeficiency. Aberrant expression of oncogenes neighboring the gamma-RV vector insertion site via induction by the enhancer element of the viral long terminal repeats (LTRs) is thought to have played a role in leukemogenesis. Consequently, RV vectors devoid of LTR enhancer elements could prove as safer tools for gene transfer. To test this hypothesis, we evaluated the immortalization ability of two RV vectors: one carrying the full-length Moloney leukemia virus (MLV) LTR and one with the same LTR in which the enhancer element was deleted [MLV self-inactivating (SIN)]. Unexpectedly, transduction with MLV SIN resulted in an only slightly and not significant decreased immortalization frequency of primary bone marrow (BM) cultures (about 37%) compared to transduction with MLV (about 48%). Similar to MLV, immortalization by MLV SIN is likely caused by insertional activation of oncogenes including Evi1, Mds1, Mef2c, and Hoxa7. Our results indicate that the MLV SIN, devoid of the LTR enhancer element, was still able to immortalize BM cells by activating nearby gene expression, indicating the need of an accurate selection of the internal promoter to obtain safer SIN RV vectors.
引用
收藏
页码:1910 / 1918
页数:9
相关论文
共 32 条
[1]   RTCGD: retroviral tagged cancer gene database [J].
Akagi, K ;
Suzuki, T ;
Stephens, RM ;
Jenkins, NA ;
Copeland, NG .
NUCLEIC ACIDS RESEARCH, 2004, 32 :D523-D527
[2]   The role of EVI1 in normal and leukemic cells [J].
Buonamici, S ;
Chakraborty, S ;
Senyuk, V ;
Nucifora, G .
BLOOD CELLS MOLECULES AND DISEASES, 2003, 31 (02) :206-212
[3]   Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells [J].
Calmels, B ;
Ferguson, C ;
Laukkanen, MO ;
Adler, R ;
Faulhaber, M ;
Kim, HJ ;
Sellers, S ;
Hematti, P ;
Schmidt, M ;
von Kalle, C ;
Akagi, K ;
Donahue, RE ;
Dunbar, CE .
BLOOD, 2005, 106 (07) :2530-2533
[4]   Stem Cell Marking With Promotor-deprived Self-inactivating Retroviral Vectors Does Not Lead to Induced Clonal Imbalance [J].
Cornils, Kerstin ;
Lange, Claudia ;
Schambach, Axel ;
Brugman, Martijn H. ;
Nowak, Regine ;
Lioznov, Michael ;
Baum, Christopher ;
Fehse, Boris .
MOLECULAR THERAPY, 2009, 17 (01) :131-143
[5]   Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells [J].
Du, Y ;
Jenkins, NA ;
Copeland, NG .
BLOOD, 2005, 106 (12) :3932-3939
[6]   Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis [J].
Du, Y ;
Spence, SE ;
Jenkins, NA ;
Copeland, NG .
BLOOD, 2005, 106 (07) :2498-2505
[7]   The role of HOX genes in malignant myeloid disease [J].
Eklund, Elizabeth A. .
CURRENT OPINION IN HEMATOLOGY, 2007, 14 (02) :85-89
[8]   LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 [J].
Hacein-Bey-Abina, S ;
Von Kalle, C ;
Schmidt, M ;
McCcormack, MP ;
Wulffraat, N ;
Leboulch, P ;
Lim, A ;
Osborne, CS ;
Pawliuk, R ;
Morillon, E ;
Sorensen, R ;
Forster, A ;
Fraser, P ;
Cohen, JI ;
de Saint Basile, G ;
Alexander, I ;
Wintergerst, U ;
Frebourg, T ;
Aurias, A ;
Stoppa-Lyonnet, D ;
Romana, S ;
Radford-Weiss, I ;
Gross, F ;
Valensi, F ;
Delabesse, E ;
Macintyre, E ;
Sigaux, F ;
Soulier, J ;
Leiva, LE ;
Wissler, M ;
Prinz, C ;
Rabbitts, TH ;
Le Deist, F ;
Fischer, A ;
Cavazzana-Calvo, M .
SCIENCE, 2003, 302 (5644) :415-419
[9]   A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency [J].
Hacein-Bey-Abina, S ;
von Kalle, C ;
Schmidt, M ;
Le Deist, F ;
Wulffraat, N ;
McIntyre, E ;
Radford, I ;
Villeval, JL ;
Fraser, CC ;
Cavazzana-Calvo, M ;
Fischer, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03) :255-256
[10]   Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 [J].
Hacein-Bey-Abina, Salima ;
Garrigue, Alexandrine ;
Wang, Gary P. ;
Soulier, Jean ;
Lim, Annick ;
Morillon, Estelle ;
Clappier, Emmanuelle ;
Caccavelli, Laure ;
Delabesse, Eric ;
Beldjord, Kheira ;
Asnafi, Vahid ;
Macintyre, Elizabeth ;
Dal Cortivo, Liliane ;
Radford, Isabelle ;
Brousse, Nicole ;
Sigaux, Francois ;
Moshous, Despina ;
Hauer, Julia ;
Borkhardt, Arndt ;
Belohradsky, Bernd H. ;
Wintergerst, Uwe ;
Velez, Maria C. ;
Leiva, Lily ;
Sorensen, Ricardo ;
Wulffraat, Nicolas ;
Blanche, Stephane ;
Bushman, Frederic D. ;
Fischer, Alain ;
Cavazzana-Calvo, Marina .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (09) :3132-3142